Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Moesin is a member of the Ezrin-Radixin-Moesin (ERM) family of cytoskeletal adaptor proteins that link the actin cytoskeleton to the plasma membrane, enabling cells to maintain structural integrity and regulate cortical rigidity[1][6][10]. Moesin contains an N-terminal FERM domain that binds membrane proteins and lipids, and a C-terminal domain that interacts with F-actin, with conformational activation regulated by phosphorylation[1][3]. Localized to cellular protrusions such as filopodia, Moesin is critical in shaping cell morphology, promoting apical-basal polarity especially in epithelial cells, and facilitating processes like cell movement, cell-cell recognition, and signal transduction[1][3][7][9]. In neuronal and epithelial contexts, Moesin is essential for morphogenesis, membrane domain organization, and acts antagonistically to Rho signaling to maintain tissue integrity[1][3][5][8]. Dysregulation or altered expression of Moesin and related ERM proteins is implicated in tumorigenesis and cancer cell migration[7]. Moesin is not a classic therapeutic target (not a receptor, enzyme, transporter, etc.), but is highly relevant in cell biology and disease pathology as a key structural and signaling organizer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Moesin (MSN).